One in Five Undergoing Telemetry for Noncardiac Indications

Share this content:
One in Five Undergoing Telemetry for Noncardiac Indications
One in Five Undergoing Telemetry for Noncardiac Indications

FRIDAY, Feb. 3, 2017 (HealthDay News) -- More than 20 percent of patients undergoing telemetry have noncardiac indications, according to a study published online Jan. 27 in the Journal of Evaluation in Clinical Practice.

Stephanie Chen, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a retrospective study to examine provider ordering practices for telemetry at a U.S.-based academic hospital. Indications were categorized per the American Heart Association guidelines.

The researchers found that the top three cardiac indications included angina/acute coronary syndrome, arrhythmias, and heart failure (35.3, 19.7, and 10.2 percent, respectively). Overall, 20.2 percent of orders were for noncardiac indications, including respiratory conditions, infection, substance abuse, bleeding, vital sign monitoring, altered mental status, and pulmonary embolus/deep vein thrombosis (17.4, 17.4, 14.0, 12.4, 10.4, 7.0, and 7.0 percent, respectively).

"One-fifth of patients were monitored on telemetry for noncardiac indications," the authors write. "We recommend further study on the benefits and risks of telemetry in these patients and systems-based changes for appropriate usage."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »